Premium
Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID ‐19 pandemic
Author(s) -
Bhattacharjee Atanu,
Patil Vijay M.,
Dikshit Rajesh,
Prabhash Kumar,
Singh Arjun,
Chaturvedi Pankaj
Publication year - 2020
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.26196
Subject(s) - medicine , covid-19 , pandemic , stage (stratigraphy) , disease , isolation (microbiology) , cancer , mortality rate , intensive care medicine , emergency medicine , infectious disease (medical specialty) , bioinformatics , biology , paleontology
Background The coronavirus infection is rapidly spreading, putting a strain on health care services across the globe. Patients with oral cancer are susceptible often immunosuppressed due to the disease and/or the treatment received. Methods We performed a simulation of the currently available data using a multistate and hazards model to provide an objective model for counseling and decision making for health care workers. Results Stage IV patients with oral cancer who did not receive treatment had progression of disease and an increased mortality rate compared to patients who receive treatment but did not contract COVID‐19. The patients who received treatment and got affected with COVID‐19 had a far worse impact and higher mortality rate than all other groups. Conclusion Isolation and deferring treatment for stage IV patients with oral cancer, so as to avoid hospital visits and contraction of COVID‐19, is an advisable strategy based on this model.